Impact of a fermented dairy protein with prebiotic fiber on gastrointestinal complaints in athletes
Official title: Effect of a Fermented Whey and Fiber Supplement on Digestive Comfort of Recreational Athletes With and Without GI Complaints
Run by Arizona State University · NCT06946017 · Data updated 2026-11-12
This study is testing if a special dairy protein with added fiber can help athletes with stomach issues feel better and improve their overall health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 114 (estimated) |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Status | Recruiting |
| Started | March 31, 2025 |
| Main results expected | September 20, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT06946017 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy men and women aged 18-50 who are recreational or competitive athletes exercising at least twice a week.
✕Probably not a fit
Patients who do not meet the inclusion criteria or have moderate GI complaints may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project investigates the effects of a fermented dairy protein with prebiotic fiber supplement on gastrointestinal (GI) complaints and overall well-being in athletes. It consists of two parts: the first part examines carbohydrate malabsorption in athletes without self-reported GI issues through a randomized double-blind crossover design, while the second part focuses on athletes with GI complaints using a randomized double-blind parallel design. Both parts include standardized exercise tests and aim to assess changes in gut microbiota, immune markers, and overall health. The study is designed to provide insights into the relationship between gut health and athletic performance.
Why it matters
Potential benefit: If successful, this study could lead to improved digestive health and quality of life for athletes experiencing GI complaints.
How similar studies have gone: Previous studies have suggested positive outcomes with similar approaches, indicating potential for success in this investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Aside from having participants fitting the inclusion and exclusion criteria below, potential participants will be screened using the gastrointestinal symptom rating scale (GSRS). Based on the outcome they will be assigned to the Part I (i.e. no self-reported GI tract issues (GSRS questionnaire score GI complaints, based on GSRS screening with all items scored \<4 (severe) and a total GSRS score ≤25), or Part II (i.e. Severe self-reported GI tract issues (GSRS questionnaire score GI complaints, based on GSRS screening with at least one item scored ≥4 (severe) and a total GSRS score ≥30). If they don't fit these criteria (i.e., having a GSRS score ranging from 26-29) they will be excluded from participation. Inclusion Criteria: * Healthy subjects living in the Phoenix area in AZ, USA during the study * Women/Men aged between 18-50 years (50-50%) * Recreational competitive and non-competitive athletes (exercise at least 2x per week with a minimal total duration of 2 hours/week) * BMI value between ≥18.5 and ≤ 30 kg/m2 * No physical limitations due to an injury (i.e., able to perform all activities associated with daily living and exercise in an independent manner). * Willing to slightly increase their energy intake via a supplement during the study period on daily basis in the morning before breakfast. * Willing and comfortable to perform multiple physical (stress) tests on a treadmill during the study. * Participants without any contraindications when scoring the Physical Activity Readiness Questionnaire (PAR-Q+). * Written informed consent * For part I: Self-perceived lactose intolerance, and/or omission of dairy products, and/or identifying as Hispanic/Latino or Asian * For part I: Determined to be lactase non-persistent (LNP) CC genotype by qPCR, and/or positive lactose intolerance test (\>20ppm increase from baseline when 25g of lactose administered) Exclusion Criteria: * Users of (sport) supplements containing probiotics and/or prebiotics and those unwilling to temporarily stop use of these supplements at least 3 weeks prior to start of the intervention * Women who plan to start or stop the use of contraceptives before or during study period * Women that have additional or worse GI symptoms during their period that can be classified as severe * Smoking * Clinical lactose intolerance * Clinical or self-perceived milk protein allergy * Diagnosed GI tract disorders or diseases * Musculoskeletal disorders * Diagnosed metabolic disorders (such as diabetes) * Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications). * Chronic use of gastric acid suppressing medication or anti-coagulants * Chronic use of anti-inflammatory medication * Use of antibiotics the past 0-6 months * Blood donation in the past 2 months * (Intending to become) Pregnant/lactating women * Significant changes in body weight during the past 4 weeks (i.e., due to reduction of body weight through limiting caloric intake, illness,) * Athletes should not aim to lose bodyweight by reducing energy intake during the study * For Part I: A hydrogen breath peak of less than 20 ppm over baseline during a lactose tolerance test
Where it's running
-
ASU Health Futures Center
Phoenix, Arizona, United States Recruiting
Study contacts
- Study coordinator: Floris C Wardenaar, PhD
- Email: Floris.wardenaar@asu.edu
- Phone: 602-543-1853
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
8-week daily supplement program to support gut and digestive health
This 8-week test will see if taking a daily two-product dietary supplement system helps adults with self-reported digestive symptoms improve stool-based biomarkers and their symptoms.
-
Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers
This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.
-
Effect of Resistance Training on Muscle Mass and Mental Health in Adults on Obesity Medication
This study tests whether 60 minutes of resistance training twice a week for 3 months helps people on GLP-1 RAs keep muscle and feel mentally better.
-
Posterior tibial nerve stimulation to help bowel function after rectal cancer surgery
This trial tests whether posterior tibial nerve stimulation can improve fecal continence and quality of life for adults who had rectal cancer surgery.
-
Prehabilitation within ERAS for gynecologic oncology surgery
This trial tests whether a pre-surgery program of tailored exercise, immunonutrition (Ocoxin), breathing exercises and psychological support combined with ERAS helps people having gynecologic cancer surgery recover faster and with fewer complications.
-
Psychosocial teleassistance programme for adults with spina bifida
This study tests a 10-week group telecare psychological program to see if it improves self-esteem, social skills, and overall psychological well-being in adults with spina bifida.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.